Learn More
Cytiva HyClone™ Research Grade Fetal Bovine Serum, South American Origin
Supplement cell culture growth with South America-sourced quality. HyClone™ Research Grade Fetal Bovine Serum, South American Origin is an irradiated serum that complies with EU regulations to provide a cost-effective solution for research applications for European customers.
1290.00 DKK - 2290.00 DKK
Specifications
Certifications/Compliance | EU regulations |
---|---|
Color | Brown |
Content And Storage | Store at -10 °C or below, Store refrigerated after thawed for up to 6 weeks |
Country of Origin | South America |
Form | Liquid |
Product Code | Brand | Sterilization Method | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Sterilization Method | Price | Quantity & Availability | |||||
12360273
|
Cytiva
SV30160.03IR |
Irradiated | N/A | ||||||
17192345
|
Cytiva
SV30160.03IR30-45 |
Irradiated |
2290.00 DKK
500mL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Research Grade Fetal Bovine Serum (FBS), South American Origin is typically sourced from Brazil and Uruguay and complies with EU regulations for strict manufacturing and quality control procedures to ensure a consistent and high-quality serum. The serum is available for customers located in Europe, Asia, and Africa.
- Sourced in EU-approved South American countries with complete traceability back to original source
- Low in antibodies and high in growth factors
- Produced using true pool technology for uniformity and consistency from bottle to bottle
- Filtered through three sequential 100 nm (0.1 μm) pore size-rated filters
- Virus panel testing according to 9 CFR 113.53
Specifications
EU regulations | |
Store at -10 °C or below, Store refrigerated after thawed for up to 6 weeks | |
Liquid | |
Sterile | |
South America (typically Brazil, Uruguay) | |
Cell culture growth |
Brown | |
South America | |
Fetal Bovine Serum | |
Irradiated | |
Virus panel testing according to 9 CFR 113.53 |